A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning
The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a
clinical setting will be assessed by comparing results with other fully three-dimensional
programs. ROB will investigate PEREGRINE for clinical use at NCI.
Interventional
Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
United States: Federal Government
990116
NCT00026936
May 1999
January 2005
Name | Location |
---|---|
National Cancer Institute (NCI) | Bethesda, Maryland 20892 |